Cargando…
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
SIMPLE SUMMARY: Renal insufficiency is frequently seen in newly diagnosed multiple myeloma and can be due to the disease itself but also caused by medical interventions or infections. Patients with severe renal insufficiency are known to have an adverse prognosis, but recently, it was shown that eve...
Autores principales: | Bachmann, Friederike, Schreder, Martin, Engelhardt, Monika, Langer, Christian, Wolleschak, Denise, Mügge, Lars Olof, Dürk, Heinz, Schäfer-Eckart, Kerstin, Blau, Igor Wolfgang, Gramatzki, Martin, Liebisch, Peter, Grube, Matthias, v Metzler, Ivana, Bassermann, Florian, Metzner, Bernd, Röllig, Christoph, Hertenstein, Bernd, Khandanpour, Cyrus, Dechow, Tobias, Hebart, Holger, Jung, Wolfram, Theurich, Sebastian, Maschmeyer, Georg, Salwender, Hans, Hess, Georg, Bittrich, Max, Rasche, Leo, Brioli, Annamaria, Eckardt, Kai-Uwe, Straka, Christian, Held, Swantje, Einsele, Hermann, Knop, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999479/ https://www.ncbi.nlm.nih.gov/pubmed/33809431 http://dx.doi.org/10.3390/cancers13061322 |
Ejemplares similares
-
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma
por: Kropff, Martin, et al.
Publicado: (2009) -
Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016) -
Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany
por: Engelhardt, Monika, et al.
Publicado: (2020) -
S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA
por: Ramberger, Evelyn, et al.
Publicado: (2023) -
From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives
por: Gay, Francesca, et al.
Publicado: (2018)